Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines.
Open Access
- 1 October 1990
- journal article
- research article
- Published by Rockefeller University Press in The Journal of cell biology
- Vol. 111 (4), 1673-1683
- https://doi.org/10.1083/jcb.111.4.1673
Abstract
The capacity of human monocytoid cell lines and peripheral blood monocytes to modulate their expression of plasminogen receptors has been assessed. After PMA stimulation, THP-1 or U937 monocytoid cells were separated into adherent and nonadherent populations. Plasminogen bound to adherent cells with similar capacity and affinity as to nonstimulated cells. In contrast, the nonadherent cells bound plasminogen with 5-17-fold higher capacity (without a change in affinity). This increase was selective as urokinase bound with similar affinity and capacity to the adherent and nonadherent populations. Upregulation of plasminogen receptors on the nonadherent monocytoid cells was rapid, detectable within 30 min, and reversible, adhesion of the nonadherent cells resulted in a sixfold decrease in plasminogen binding within 90 min. The increase in plasminogen binding to the nonadherent cells was associated with a marked increase in their capacity to generate plasmin activity from cell-bound plasminogen. PMA stimulation of human peripheral blood monocytes increased their expression of plasminogen receptors by two- to fourfold. This increase was observed in both adherent and nonadherent monocytes. Freshly isolated monocytes maximally bound 5.0 .times. 105 plasminogen molecules per cell, whereas monocytes cultured for 18 h or more maximally bound 1.7 .times. 107 molecules per cell, a 30-fold difference in receptor number. These results indicate that both monocytes and monocytoid cell lines can rapidly and markedly regulate their expression of plasminogen binding sites. As enhanced plasminogen binding is correlated with an increased capacity to generate plasmin, an enzyme with broad substrate recognition, modulation of plasminogen receptors may have profound functional consequences.This publication has 58 references indexed in Scilit:
- Human monocytes can produce tissue-type plasminogen activator.The Journal of Experimental Medicine, 1989
- Limited proteolysis of tumor cells increases their plasmin‐binding abilityFEBS Letters, 1989
- Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.The Journal of cell biology, 1989
- Binding of Lys-plasminogen to monocytes/macrophages.Journal of Clinical Investigation, 1988
- Parallel induction of fibrinolysis and receptors for plasminogen and urokinase by interferon gamma on U937 cellsBiochemical and Biophysical Research Communications, 1988
- Evidence of intracellular and trans‐acting differentiation‐inducing activity in human promyelocytic leukemia HL‐60 cells: Its possible involvement in process of cell differentiation from a commitment step to a phenotype‐expression stepJournal of Cellular Physiology, 1988
- 1,25-Dihydroxyvitamin D3 induces collagen binding to the human monocyte line U937.Journal of Clinical Investigation, 1987
- Cryptic urokinase binding sites on human foreskin fibroblastsBiochemical and Biophysical Research Communications, 1985
- Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TGlymphocytesEuropean Journal of Immunology, 1980
- Macrophage plasminogen activator: Modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotidesCell, 1976